112 related articles for article (PubMed ID: 26371231)
21. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
Kramer RA; Greene K; Ahmad S; Vistica DT
Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
[TBL] [Abstract][Full Text] [Related]
22. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
Reliene R; Schiestl RH
Carcinogenesis; 2006 Feb; 27(2):240-4. PubMed ID: 16162646
[TBL] [Abstract][Full Text] [Related]
23. TRPM2 channel protective properties of N-acetylcysteine on cytosolic glutathione depletion dependent oxidative stress and Ca2+ influx in rat dorsal root ganglion.
Özgül C; Nazıroğlu M
Physiol Behav; 2012 May; 106(2):122-8. PubMed ID: 22300897
[TBL] [Abstract][Full Text] [Related]
24. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
Bertsche U; Schorn H
Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
[TBL] [Abstract][Full Text] [Related]
25. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
Mitchell JB; Russo A; Biaglow JE; McPherson S
Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
[TBL] [Abstract][Full Text] [Related]
26. Effects of emphysema and training on glutathione oxidation in the hamster diaphragm.
Heunks LM; Bast A; van Herwaarden CL; Haenen GR; Dekhuijzen PN
J Appl Physiol (1985); 2000 Jun; 88(6):2054-61. PubMed ID: 10846018
[TBL] [Abstract][Full Text] [Related]
27. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase.
Messina JP; Lawrence DA
J Immunol; 1989 Sep; 143(6):1974-81. PubMed ID: 2789253
[TBL] [Abstract][Full Text] [Related]
28. Regulation of gamma-glutamylcysteine synthetase subunit gene expression in retinal Müller cells by oxidative stress.
Lu SC; Bao Y; Huang ZZ; Sarthy VP; Kannan R
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1776-82. PubMed ID: 10393048
[TBL] [Abstract][Full Text] [Related]
29. Minimal ovarian upregulation of glutamate cysteine ligase expression in response to suppression of glutathione by buthionine sulfoximine.
Hoang YD; Avakian AP; Luderer U
Reprod Toxicol; 2006 Feb; 21(2):186-96. PubMed ID: 16183247
[TBL] [Abstract][Full Text] [Related]
30. The responses of Ht22 cells to oxidative stress induced by buthionine sulfoximine (BSO).
Chen J; Small-Howard A; Yin A; Berry MJ
BMC Neurosci; 2005 Feb; 6():10. PubMed ID: 15707499
[TBL] [Abstract][Full Text] [Related]
31. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
Yang B; Keshelava N; Anderson CP; Reynolds CP
Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
[TBL] [Abstract][Full Text] [Related]
32. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
O'Dwyer PJ; Hamilton TC; LaCreta FP; Gallo JM; Kilpatrick D; Halbherr T; Brennan J; Bookman MA; Hoffman J; Young RC; Comis RL; Ozols RF
J Clin Oncol; 1996 Jan; 14(1):249-56. PubMed ID: 8558205
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte growth factor protects RPE cells from apoptosis induced by glutathione depletion.
Jin M; Yaung J; Kannan R; He S; Ryan SJ; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4311-9. PubMed ID: 16249513
[TBL] [Abstract][Full Text] [Related]
34. Zinc toxicity in various lung cell lines is mediated by glutathione and GSSG reductase activity.
Walther UI; Wilhelm B; Walther S; Mückter H; Fichtl B
Biol Trace Elem Res; 2000; 78(1-3):163-77. PubMed ID: 11314976
[TBL] [Abstract][Full Text] [Related]
35. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.
Bailey HH; Mulcahy RT; Tutsch KD; Arzoomanian RZ; Alberti D; Tombes MB; Wilding G; Pomplun M; Spriggs DR
J Clin Oncol; 1994 Jan; 12(1):194-205. PubMed ID: 8270977
[TBL] [Abstract][Full Text] [Related]
36. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
Armstrong JS; Steinauer KK; Hornung B; Irish JM; Lecane P; Birrell GW; Peehl DM; Knox SJ
Cell Death Differ; 2002 Mar; 9(3):252-63. PubMed ID: 11859408
[TBL] [Abstract][Full Text] [Related]
37. [Experimental study on the effects of BSO, GSH, vitamin C and DMPS on the nephrotoxicity induced by mercury].
Zhao-Fa X; Jing-Hua Y; Jia-Ming Y; Zhong-Wei Y
Wei Sheng Yan Jiu; 2005 Sep; 34(5):533-6. PubMed ID: 16329589
[TBL] [Abstract][Full Text] [Related]
38. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Kang YJ
Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
[TBL] [Abstract][Full Text] [Related]
39. Effects of glutathione depletion on cadmium-induced metallothionein synthesis, cytotoxicity, and proto-oncogene expression in cultured rat myoblasts.
Shimizu M; Hochadel JF; Waalkes MP
J Toxicol Environ Health; 1997 Aug; 51(6):609-21. PubMed ID: 9242231
[TBL] [Abstract][Full Text] [Related]
40. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
